I would imagine PAF would be forced to scale down their holdings should DNA head north from current levels.
PAF do have an unusually large weighting to DNA (at circa 10% of the portfolio), given they've got the whole Asia Pacific region to choose from (including US listed Asian focused stocks).
Ann: AGM Presentations, page-35
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DNA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $38.29M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 2.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.1¢ | 250000 | 1 |
View Market Depth
| Last trade - 16.12pm 04/11/2024 (20 minute delay) ? |
| DNA (ASX) Chart |
Day chart unavailable